Kelly, Michael R. http://orcid.org/0000-0003-4642-0118
Wisniewska, Kamila http://orcid.org/0000-0002-6388-7265
Regner, Matthew J. http://orcid.org/0000-0001-9838-568X
Lewis, Michael W.
Perreault, Andrea A.
Davis, Eric S. http://orcid.org/0000-0003-4051-3217
Phanstiel, Douglas H. http://orcid.org/0000-0003-2123-0051
Parker, Joel S.
Franco, Hector L. http://orcid.org/0000-0001-9354-0679
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5T32-CA217824, 5T32-CA217824, 5-P50-CA058223-25)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32-GM067553, R35-GM128645)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Susan G. Komen (CCR19608601)
V Foundation for Cancer Research (V2019-015)
Rivkin Center for Ovarian Cancer (N/A)
Article History
Received: 18 May 2021
Accepted: 8 July 2022
First Online: 22 July 2022
Competing interests
: The authors declare no competing interests.